Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Cinchocaine is an anesthetic used for local or regional anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia.
- Mechanism
- Curator reviewed
Local anesthetics block both the initiation and conduction of nerve impulses by decreasing the neuronal membrane's permeability to sodium ions through sodium channel inhibition. This reversibly stabilizes the membrane and inhibits depolarization, resulting in the failure of a propagated action potential and subsequent conduction blockade.
- Primary indication
- For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such...Curator reviewed · 6 structured indications
- Formula / weight
- C20H29N3O2 · 343.4632 g/mol (avg)
- First approval
- Canada, 2003 · United States, 2012
- Also known as
- Dibucaine
- Brand names
- Nupercainal
- Proctol
Resolves to
PUFQVTATUTYEAL-UHFFFAOYSA-NSMILESCCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CCWhat you can answer from here — as of September 23, 2026
Which drugs share a target with Cinchocaine, and which of those have an active Phase 3 trial?